相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of 2H-chromone-4-one based sulfonamide derivatives as potent retinoic acid receptor-related orphan receptor γt inverse agonists
Lei Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Discovery of a novel RORγ antagonist with skin-restricted exposure for topical treatment of mild to moderate psoriasis
Suxing Liu et al.
SCIENTIFIC REPORTS (2021)
Discovery of novel N-sulfonamide-tetrahydroquinolines as potent retinoic acid receptor-related orphan receptor γt inverse agonists for the treatment of autoimmune diseases
Nannan Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome A Randomized Clinical Trial
V. Marco Ranieri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Discovery of [1,2,4]Triazolo[1,5-a]pyridine Derivatives as Potent and Orally Bioavailable RORγt Inverse Agonists
Ryota Nakajima et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt
Christian Gege et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach
Christoph Steeneck et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24
Wai Po Chong et al.
IMMUNITY (2020)
RORγ Structural Plasticity and Druggability
Mian Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Asymmetric Synthesis of a 5,6,7,8-Tetrahydro-1,6-naphthyridine Scaffold Leading to Potent Retinoid-Related Orphan Receptor γt Inverse Agonist TAK-828F
Ryoji Tsuruoka et al.
JOURNAL OF ORGANIC CHEMISTRY (2020)
Novel Tricyclic Pyroglutamide Derivatives as Potent RORγt Inverse Agonists Identified using a Virtual Screening Approach
Qingjie Liu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Structure-based Discovery of Phenyl (3-Phenylpyrrolidin-3-yI)sulfones as Selective, Orally Active RORγt Inverse Agonists
James J. -W. Duan et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists
Jerome Amaudrut et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Discovery of N-indanyl benzamides as potent RORγt inverse agonists
Jinlong Tian et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Molecular dynamics simulations on RORγt: insights into its functional agonism and inverse agonism
Cong-min Yuan et al.
ACTA PHARMACOLOGICA SINICA (2019)
5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives as inhibitors of full-length RORγt
Chuyu Lao et al.
BIOORGANIC CHEMISTRY (2019)
Atomistic simulations shed new light on the activation mechanisms of RORγ and classify it as Type III nuclear hormone receptor regarding ligand-binding paths
Suwipa Saen-Oon et al.
SCIENTIFIC REPORTS (2019)
Antagonizing Retinoic Acid-Related-Orphan Receptor Gamma Activity Blocks the T Helper 17/Interleukin-17 Pathway Leading to Attenuated Pro-inflammatory Human Keratinocyte and Skin Responses
Florence Ecoeur et al.
FRONTIERS IN IMMUNOLOGY (2019)
Identification of novel quinazolinedione derivatives as RORγt inverse agonist
Yoshiyuki Fukase et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Discovery of orally efficacious RORγt inverse agonists, part 1: Identification of novel phenylglycinamides as lead scaffolds
Junya Shirai et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Sulfoximines as potent RORc inverse agonists
Gilles Ouvry et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity
Hua Gong et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Discovery of carbazole carboxamides as novel RORγt inverse agonists
Yafei Huang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design
Frank Narjes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Molecular Mechanism of Action of RORt Agonists and Inverse Agonists: Insights from Molecular Dynamics Simulation
Nannan Sun et al.
MOLECULES (2018)
Ternary crystal structure of human RORγ ligand-binding-domain, an inhibitor and corepressor peptide provides a new insight into corepressor interaction
Masato Noguchi et al.
SCIENTIFIC REPORTS (2018)
Discovery of Retinoic Acid-Related Orphan Receptor γt Inverse Agonists via Docking and Negative Image-Based Screening
Sanna Rauhamaki et al.
ACS OMEGA (2018)
DESIGN AND SYNTHESIS OF 1,3,5-TRIAZINE DERIVATIVES AS NOVEL INVERSE AGONISTS OF NUCLEAR RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR-γ
Kazuma Kaitoh et al.
HETEROCYCLES (2017)
Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo
Ulf Guendisch et al.
PLOS ONE (2017)
Structural States of RORgt: X-ray Elucidation of Molecular Mechanisms and Binding Interactions for Natural and Synthetic Compounds
Joerg Kallen et al.
CHEMMEDCHEM (2017)
Synthesis of dihydroimidazole tethered imidazolinethiones and their activity as novel antagonists of the nuclear retinoic acid receptor-related orphan receptors (RORs)
Adel Nefzi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells)
Naohiro Yoshida et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ
Roine I. Olsson et al.
CHEMMEDCHEM (2016)
N-Arylsulfonyl Indolines as Retinoic Acid Receptor-Related Orphan Receptor γ (RORγ) Agonists
Christelle Doebelin et al.
CHEMMEDCHEM (2016)
Synthesis and Biological Evaluation of New Triazolo- and Imidazolopyridine RORγt Inverse Agonists
Samuel Hintermann et al.
CHEMMEDCHEM (2016)
ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
Junjian Wang et al.
NATURE MEDICINE (2016)
The Nuclear Receptor, RORγ, Regulates Pathways Necessary for Breast Cancer Metastasis
Tae Gyu Oh et al.
EBIOMEDICINE (2016)
Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin
Susan H. Smith et al.
PLOS ONE (2016)
Discovery of novel pyrazole-containing benzamides as potent ROR gamma inverse agonists
Tao Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Discovery of biaryl carboxylamides as potent RORγ inverse agonists
Jianhua Chao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists
Benjamin P. Fauber et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Inhibition of RORγt activity and Th17 differentiation by a set of novel compounds
Qingfeng Ding et al.
BMC IMMUNOLOGY (2015)
Identification of Natural RORγ Ligands that Regulate the Development of Lymphoid Cells
Fabio R. Santori et al.
CELL METABOLISM (2015)
Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors
Yonghui Wang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Identification of an allosteric binding site for RORγt inhibition
Marcel Scheepstra et al.
NATURE COMMUNICATIONS (2015)
Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl) amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors
Yonghui Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
A reversed sulfonamide series of selective RORc inverse agonists
Monique B. van Niel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms
Sheng Xiao et al.
IMMUNITY (2014)
iLOGP: A Simple, Robust, and Efficient Description of n-Octanol/Water Partition Coefficient for Drug Design Using the GB/SA Approach
Antoine Daina et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation
Pejman Soroosh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Discovery of Tertiary Amine and Indole Derivatives as Potent RORγt Inverse Agonists
Ting Yang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc
Benjamin P. Fauber et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
RORtIL-17 neutrophils play a critical role in hepatic ischemiareperfusion injury
Zhongming Tan et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2013)
Identification of Potent and Selective Diphenylpropanamide RORγ Inhibitors
Jun R. Huh et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Attenuation of Acute Graft-versus-Host Disease in the Absence of the Transcription Factor RORγt
LeShara M. Fulton et al.
JOURNAL OF IMMUNOLOGY (2012)
Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity
Jun R. Huh et al.
NATURE (2011)
Analysis of protein-ligand interactions by fluorescence polarization
Ana M. Rossi et al.
NATURE PROTOCOLS (2011)
A second class of nuclear receptors for oxysterols: Regulation of RORα and RORγ activity by 24S-hydroxycholesterol (cerebrosterol)
Yongjun Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Regulated Expression of Nuclear Receptor RORγt Confers Distinct Functional Fates to NK Cell Receptor-Expressing RORγt+ Innate Lymphocytes
Cedric Vonarbourg et al.
IMMUNITY (2010)
ESOL: Estimating aqueous solubility directly from molecular structure
JS Delaney
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2004)
Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties
P Ertl et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
